Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2490366 | 0.98 | POLB (0.45) | POLBKMT2AMEN1TSHRPIK3CD | |
| SCHEMBL2794567 | 0.93 | KMT2A (0.41) | POLBKMT2AMEN1TSHRPIK3CD | |
| SCHEMBL7937319 | 0.91 | KMT2A (0.51) | POLBKMT2AMEN1TSHRPIK3CD | |
| SCHEMBL19514128 | 0.89 | KMT2A (0.50) | POLBKMT2AMEN1TSHRPIK3CD | |
| SCHEMBL9011466 | 0.87 | PIK3CD (0.50) | POLBKMT2AMEN1TSHRPIK3CD | |
| SCHEMBL8560901 | 0.87 | KMT2A (0.49) | POLBKMT2AMEN1TSHRPIK3CD | |
| SCHEMBL8558755 | 0.85 | KMT2A (0.48) | POLBKMT2AMEN1TSHRPIK3CD | |
| SCHEMBL20687601 | 0.85 | KMT2A (0.48) | POLBKMT2AMEN1TSHRPIK3CD | |
| SCHEMBL8559626 | 0.85 | KMT2A (0.46) | POLBKMT2AMEN1TSHRPIK3CD | |
| SCHEMBL8561376 | 0.84 | KMT2A (0.47) | POLBKMT2AMEN1TSHRPIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2121559-B1 | CATALYTIC METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2015-08-26 | — | — | EP | claimed |
| US-8476387-B2 | Catalytic process for preparing (meth)acrylic esters of N-hydroxyalkylated lactams | BASF SE (DE) | 2013-07-02 | — | — | US | claimed |
| CN-101300220-B | Catalytic process for preparing (meth) acrylic esters from N-hydroxyalkylated lactams | BASF AG | 2013-02-20 | — | — | CN | claimed |
| US-8367788-B2 | Catalytic process for preparing (meth)acrylic esters of N-hydroxyalkylated lactams | BASF SE (DE) | 2013-02-05 | — | — | US | claimed |
| EP-1945602-B1 | HYDROGEN-CATALYSED PROCESS FOR PREPARING (METH)ACRYLATES OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2012-08-01 | — | — | EP | claimed |
| US-7750100-B2 | Catalytic process for preparing (meth)acrylates from N-hydroxyalkylated lactams | BASF AKTIENGESELLSCHAFT (DE) | 2010-07-06 | — | — | US | claimed |
| US-20100113725-A1 | CATALYTIC PROCESS FOR PREPARING (METH)ACRYLIC ESTERS OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2010-05-06 | — | — | US | claimed |
| US-20100010236-A1 | CATALYTIC PROCESS FOR PREPARING (METH)ACRYLIC ESTERS OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2010-01-14 | — | — | US | claimed |
| CN-101622228-A | Catalytic process for preparing (meth) acrylic esters of N-hydroxyalkylated lactams | BASF SE | 2010-01-06 | — | — | CN | claimed |
| EP-2121595-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ESTERS OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2009-11-25 | — | — | EP | claimed |
| EP-2121559-A1 | CATALYTIC METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2009-11-25 | — | — | EP | claimed |
| CN-101300220-A | Catalytic process for preparing (meth) acrylic esters from N-hydroxyalkylated lactams | BASF AG (DE) | 2008-11-05 | — | — | CN | claimed |
| WO-2008098885-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ESTERS OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2008-08-21 | — | — | WO | claimed |
| WO-2008098887-A1 | CATALYTIC METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2008-08-21 | — | — | WO | claimed |
| EP-1945602-A1 | HYDROGEN-CATALYSED PROCESS FOR PREPARING (METH)ACRYLATES OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2008-07-23 | — | — | EP | claimed |
| US-20070123673-A1 | CATALYTIC PROCESS FOR PREPARING (METH)ACRYLATES FROM N-HYDROXYALKYLATED LACTAMS | BASF AKTIENGESELLSCHAFT (DE) | 2007-05-31 | — | — | US | claimed |
| WO-2007051738-A1 | HYDROGEN-CATALYSED PROCESS FOR PREPARING (METH)ACRYLATES OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2007-05-10 | — | — | WO | claimed |
| US-4397750-A | ALKENYLSUCCINIC AHYDRIDE DERIVATIVES | MOBIL OIL CORPORATION (US) | 1983-08-09 | — | — | US | claimed |
| EP-2121559-B1 | CATALYTIC METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2015-08-26 | — | — | EP | disclosed |
| US-3968148-A | Copolymers of 1-alkenes and acrylic acid derivatives | ROHM AND HAAS COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100010236-A1 | CATALYTIC PROCESS FOR PREPARING (METH)ACRYLIC ESTERS OF N-HYDROXYALKYLATED LACTAMS | COASY, MCCC2, PAM | POLB 450/4885KMT2A 863/4885MEN1 698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.